Quantitative community analysis of novel therapeutics against multispecies vaginal biofilms

  • Kean, Ryan (PI)
  • Ramage, Gordon, University of Glasgow (CoI)
  • Corcoran, David, CC Biotech (CoI)
  • Cummings, Matthew, CC Biotech (CoI)

Project Details

Description

Bacterial vaginosis (BV) represents both a significant health and economic burden. Commonly associated with this infection is treatment failure due to the presence of microbial communities known as biofilms. In this project we aim to develop testing platforms to assess the efficacy of a novel therapeutic targeting BV.
Short titleTargeted therapy for BV
StatusActive
Effective start/end date13/09/2112/03/22

Funding

  • National Biofilms Innovation Centre: £46,666.00

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.